0001567619-22-008630.txt : 20220418 0001567619-22-008630.hdr.sgml : 20220418 20220418190429 ACCESSION NUMBER: 0001567619-22-008630 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220414 FILED AS OF DATE: 20220418 DATE AS OF CHANGE: 20220418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Love Douglas CENTRAL INDEX KEY: 0001818520 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39402 FILM NUMBER: 22833065 MAIL ADDRESS: STREET 1: C/O ANNEXON, INC. STREET 2: 180 KIMBALL WAY, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Annexon, Inc. CENTRAL INDEX KEY: 0001528115 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 275414423 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 SIERRA POINT PARKWAY STREET 2: BLDG C SUITE 200 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (650)-822-5500 MAIL ADDRESS: STREET 1: 1400 SIERRA POINT PARKWAY STREET 2: BLDG C SUITE 200 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc1.xml FORM 4 X0306 4 2022-04-14 0 0001528115 Annexon, Inc. ANNX 0001818520 Love Douglas C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President & CEO Common Stock 2022-04-14 4 P 0 60000 2.4469 A 200942 D The shares were purchased in multiple transactions at prices ranging from $2.41 to $2.50, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Includes 160,942 shares held and 40,000 restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. /s/ Jennifer Lew, as Attorney-in-Fact for Douglas Love 2022-04-18